This finding provides the first demonstration that FBN1 deficiency leads to the decline of Cav1.2 expression due to TGF-β1 over-expression, which inhibits the proliferation of HASMCs in MFS patients (MFS-HASMCs). This evidence concerns the gene FBN1 and Marfan syndrome.